Biogen up 38% on a really junky equivocal FDA appr
Post# of 36537
(Total Views: 265)
Posted On: 06/07/2021 7:41:20 PM
Biogen up 38% on a really junky equivocal FDA approval.
It is risky. Some people get bleeding in their brains.
One study, no improvement.
Second study, slight improvement.
Maybe the fact that it gets rid of amyloid protein might be useful with some other drug that can take advantage of that.
It is risky. Some people get bleeding in their brains.
One study, no improvement.
Second study, slight improvement.
Maybe the fact that it gets rid of amyloid protein might be useful with some other drug that can take advantage of that.
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼